Biogen : FDA Approves First Oral Treatment For Postpartum Depression

The U.S. Food and Drug Administration approved Zurzuvae (zuranolone) 50 mg for adults with postpartum depression, Sage Therapeutics Inc. (SAGE) and Biogen Inc. (BIIB) said in a statement. Zurzuvae is the first and only oral, once-daily, 14-day treatment that can provide rapid improvements in depressive symptoms for women with postpartum depression. Until now, treatment for postpartum depression was only available […]

Read more

‘Steel prices have already bottomed out’

‘While lower steel prices may impact a part of the quarter, this will be offset by softer raw material prices.’ Off the back of the India story, JSW Steel has laid out an expansion plan to increase its capacity from 28.2 million tonnes (mt) to 37 mt by 2024-25 (FY25), with further ambitions to reach 50 mt in the medium […]

Read more

Blackstone, Baring in race to acquire up to 20% stake in Cipla

In one of the largest potential transactions this year, private-equity majors Blackstone and Baring have initiated talks with the Hamied family, the promoters of pharmaceutical firm Cipla, to acquire up to 20 per cent in the company. The family owns 33.47 per cent and may become minority owners if the talks succeed, said a source close to the development. It […]

Read more

European Shares Seen Lower As Yields Rise After BOJ Policy Tweak

European stocks may drift lower on Friday as a batch of upbeat economic data from the United States helped quell fears of an imminent recession but revived rate hike fears. Asian stocks traded mostly lower, with Chinese and Hong Kong markets bucking the regional trend, after China’s housing minister Ni Hong urged efforts to help ease a protracted property slump. […]

Read more

U.S. Stocks Give Back Ground After Early Move To The Upside

Stocks showed a strong move to the upside in early trading on Thursday but have given back ground over the course of the session. The major averages have pulled back well off their highs of the session, with the Dow falling into negative territory. After surging as much as 1.7 percent early in the session, the Nasdaq is up 58.59 […]

Read more

ECB Hikes Rates Again As Lagarde Leaves Door Open For Pause Ahead

The European Central Bank raised its interest rates on Thursday, as expected, for the ninth policy session in a row citing the prospect of inflation in the euro area staying too high for too long, while the bank chief Christine Lagarde signaled that policymakers are having an open mind regarding future rate decisions, suggesting that a pause may be on […]

Read more

Warner Bros. Discovery CFO Gunnar Wiedenfels On Strikes Savings “In Low $100M Range”; Release Dates Remain Fluid, Outlook “Assumes Return To Work In Early September”

While Warner Bros Discovery CEO David Zaslav on this morning’s Q2 earnings call for the conglom is “hopeful that all sides will get back to the negotiating room soon and that these strikes get resolved in a way that the writers and actors feel that they are fairly compensated,” WBD CFO Gunnar Wiedenfels served up info that there were “modest […]

Read more

At $112 bn, Reliance Retail value may be almost double RIL’s O2C business

Reliance Industries’ (RIL’s) retail arm, Reliance Retail, is now valued at nearly twice the amount of its decades-old and lucrative oil-to-chemical (O2C) division. Bernstein’s latest report on the conglomerate projects a valuation of $112 billion for its retail business, dwarfing the $57 billion valuation of its O2C division. In addition, the research firm valued Jio Platforms, the company’s telecom arm, […]

Read more
1 29 30 31 32 33 777